Rubra Medicaments has informed that it attached the Certificate under Regulation 40(9) of the SEBI (LODR) Regulations, 2015 for the half year ended March 31, 2022 given by Practising Company Secretary in the prescribed format.
The above information is a part of company’s filings submitted to BSE.